Thank you Holly Scott for capturing our progress with our CEO David N Constantine. It is an exciting space to be working in right now. Both #Neuromodulation and novel pelvic health therapy are on notable growth paths and our work is positioned to be a key contributor to a dramatic improvement to what clinicians and patients have available to them. #mixedurinaryincontinence #OAB #SUI #PelvicHealth
Vice President & Partner at The Mullings Group | Global Medical Device & Life Sciences | Executive Search-Building Companies and Careers
#Neuromodulation opportunities are one of the largest areas of expected market growth trends in the next 3-5 years. The market seems to agree based on the incredible investment happening in #pelvichealth year to date. Boston Scientific acquires Axonics, Inc. for $3.4 Bil Amber Therapeutics raises $100 Mil Neuspera Medical Inc. announced $23 Mil raise Avation Medical raises $22 Mil All of this is why my discussion with David N Constantine, Co-Founder and CEO of Juniper Biomedical, couldn't have happened at a better time. David and the team are bullishly focusing on revolutionizing pelvic health therapies through precision neuromodulation. Check out our full discussion on Tech Talks in link below.